BBOT
NASDAQ · Biotechnology
Bridgebio Oncology Therapeut
$2.17
-0.13 (-5.65%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,886.2% upside
Low Target
$22.76
Average Target
$43.10
High Target
$48.38
Current Price
$2.17
Current
$2.17
$2.17
Target
$43.10
$43.10
$22.76
$43.10 avg
$48.38
Scenario Analysis
Bear Case
$22.76
948.8%
Low target
Base Case
$43.10
+1,886.2%
Avg target
Bull Case
$48.38
+2,129.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$14.87
-85.4% from high
52-Week Low
$2.22
+-2.3% from low
Target vs 52W High
$43.10
+189.8% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-0.70
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |